Madrigal Pharmaceuticals, Inc.
2019 Q4 - 2025 Q4 (24 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 9,356 | 0.0% | 16,052 | 12/31/2025 |
| 2025 Q2 | 8/14/2025 | 7,087 | 0.0% | 23,416 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 7,600 | 0.0% | 22,945 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 7,430 | 0.0% | 24,080 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 6,357 | 0.0% | 29,957 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 9,996 | 0.0% | 35,678 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 8,209 | 0.0% | 30,741 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 3,720 | 0.0% | 16,079 | 12/31/2023 |
| 2023 Q3 | 11/15/2023 | 2,024 | 0.0% | 13,860 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 1,316 | 0.0% | 5,696 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 1,282 | 0.0% | 5,290 | 3/31/2023 |
| 2022 Q4 | 8/11/2023 | 1,447 | 0.0% | 4,986 | 12/31/2022 |
| 2022 Q3 | 8/11/2023 | 331 | 0.0% | 5,092 | 9/30/2022 |
| 2022 Q2 | 8/11/2023 | 372 | 0.0% | 5,194 | 6/30/2022 |
| 2022 Q1 | 8/11/2023 | 489 | 0.0% | 4,980 | 3/31/2022 |
| 2021 Q4 | 2/16/2022 | 524 | 0.0% | 6,183 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 489 | 0.0% | 6,127 | 9/30/2021 |
| 2021 Q2 | 8/12/2021 | 642 | 0.0% | 6,587 | 6/30/2021 |
| 2021 Q1 | 5/3/2021 | 601 | 0.0% | 5,137 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 601 | 0.0% | 5,407 | 12/31/2020 |
| 2020 Q3 | 11/9/2020 | 626 | 0.0% | 5,276 | 9/30/2020 |
| 2020 Q2 | 8/10/2020 | 552 | 0.0% | 5,369 | 6/30/2020 |
| 2020 Q1 | 5/15/2020 | 375 | 0.0% | 5,619 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 447 | 0.0% | 4,907 | 12/31/2019 |